SCPS News and Press, Scopus BioPharma Inc. From 09/22/21

Alan Horsager, Ph.D., President and Chief Executive Officer of Duet Therapeutics, will present on CpG-STAT3 RNA Silencing and Antisense inhibitors Presentations to cover CpG-STAT3siRNA (DUET-01) and CpG-STAT3ASO (DUET-02) NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Sc...

New patent covers compound and composition and methods of use for CpG-STAT3 Antisense inhibitor (CpG-STAT3ASO) New patent positions Scopus BioPharma’s Subsidiary — Duet Therapeutics — to pursue opportunities arising from China’s burgeoning biotech...

Dr. Rossi is a world leader in the development of RNA interference, the Lidow Family Research Endowed Chair and Professor and Chair of the Department of Molecular and Cellular Biology at the Beckman Research Institute of the City of Hope National Medical Center, and a serial founder and e...

NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) , a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced it will be presenting...

Dr. Kortylewski is the Leading Authority on Bi-Functional Oligonucleotide Cancer Therapeutics and a Professor in the Department of Immuno-Oncology at the Beckman Research Institute at City of Hope National Medical Center Dr. Kortylewski to Chair and Present at the 14 th Annual...

Gainers: Cellect Biotechnology (NASDAQ:APOP) +39%. NeuroOne Medical Technologies (NASDAQ:NMTC) +17%. Enveric Biosciences (NASDAQ:ENVB) +16%. Impel NeuroPharma (NASDAQ:IMPL) +12%. Progenity (NASDAQ:PROG) +10%. Losers: Forte Biosciences (NASDAQ:FBRX) -81%. Evelo Biosciences (NASDAQ:EV...

NEW YORK, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) , a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced that Alan Horsager, P...

Gainers: Innate Pharma (NASDAQ:IPHA) +32%, Tiziana Life Sciences (NASDAQ:TLSA) +16%, Verrica Pharmaceuticals (NASDAQ:VRCA) +12%, NeuroBo Pharmaceuticals (NASDAQ:NRBO) +12%, Scopus BioPharma (NASDAQ:SCPS) +11%. Losers: Assembly Biosciences (NASDAQ:ASMB) ...

Duet Therapeutics Integrates Immunotherapy Assets of Scopus and Olimmune, Acquired by Scopus in June 2021 Integration Creates Comprehensive, Industry-Leading Portfolio of Bi-Functional Cancer-Targeting Oligonucleotides NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) -- ...

Penny Stocks Insiders Are Scooping Up Is there a secret to finding the best penny stocks to buy right now? If you ask some traders, they’ll tell you to follow the money. But what does that actually mean? This entails following big trades made in the market & that goes for bot...